Search images on Google Product Monograph
Active Ingredients:
- risankizumab, 60 MG/ML
DIN: 02532107
Dosage Form(s): SOLUTION
Route(s) of Administration: INTRAVENOUS
Description: SINGLE USE VIAL
Schedule: Prescription
Company: ABBVIE CORPORATION
ATC:
- L04 - IMMUNOSUPPRESSANTS (ATC, WHO, Wiki)
- L04A - IMMUNOSUPPRESSANTS (ATC, WHO)
- L04AC - Interleukin inhibitors (ATC, WHO)
- L04AC18 - RIZANKIZUMAB (WHO)